## 

## 

||**Page**|
|---|---|
|Trustees' Annual Report|2-32|
|StatementofTrustees'responsibilities|30-31|
|Independent Auditor's report|33-36|
|Consolidated Statement of FinancialActivities|37|
|Charity only Statement of Financial Activities|`38`|
|Consolidated Balance sheet|`39`|
|Charity only Balance Sheet|40|
|Consolidated Cash flow statement|41-42|
|Charity only Cash flow statement|43-44|
|Notes to the accounts|45-74|





## 

|Charity numbers:|England & Wales 1046854|Scotland SC037596|
|---|---|---|
|Company number:|03059425||
|Registered PrincipalOffice:|Cotton Exchange Building||
||Old HallStreet,Liverpool,L3 9LQ||



## 

## 

## 

## 



## 



## 

## 

## 



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

|ADVERT|ADVERT|REACH|CLICKS|CLICK|ENGAGEMENT|COMMENTS/|
|---|---|---|---|---|---|---|
|||||THRU RATE||REACTIONS|
|||||(CTR)|||
|•|Animated lungs|6,092|202|6.2%|5327|52|
|•|Female|4,592|160|8.2%|4035|32|
||participant||||||
||having||||||
||spirometry||||||
|•|Nurse talking|3,832|183|6.4%|3737|25|
||head||||||
|•|Male patient /|3,471|68|5.0%|2480|27|
||lung cancer||||||
||survivor||||||



## 

## 

## 



## 

## 

|**Event**||**Reach**|**Registrations**|
|---|---|---|---|
|•|60s Retro Run|127,577|613|
|•|70s Retro Run|484,683|705|
|•|80s Retro Run|862,727|1149|
|•|90s Retro Run|770,666|1682|
|•|Christmas Tapathon|72,992|530|
|•|[asterRun|356,313|1713|
|•|Retro Running Series|104,975|497|
|•|Snowman Sketch|179,211|250|
|•|Spooky Welly Walk|320,143|754|
|•|Spring Trail|341,487|42|
|•|Summer Tapathon|508,932|1192|
|**TOTAL**||**4,129,706**|**8,022[9]**|



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

|•|AMGEN GLOBAL|£30,000|
|---|---|---|
|•|ASTRA ZENECA UK|£38,226|
|•|Boehrhinger|£30,742|
|•|E.R.SQUIBB|£30,797|
|•|ELI LILLY CO|£30,000|
|•|JANSSEN|£19,000|
|•|MERCK|£40,300|
|•|NOVARTIS|£32,902|
|•|PFIZER|£119,000|
|•|ROCHE PRODUCTS LTD|£50,600|
|•|TAKEDA PHARMACEUTICAL|£66,462|
|•|VIRGO|£8,000|



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



Roy Castle Lung Cancer Foundation
Trustsès. Consolidated Annual Reportforthe year ended 31 December 2020
Company law requires the trustees to prepa￿ financial st*wnents for each financial year which give a
true and fair view of the state of affair5 oflhe Charrtab￿ company and the group and of the incoming
resourtes 8nd applKalion of resources, induding the income ar￿ expendrture, ofthe charrtable group
that period. In FKeparing the￿ finan¢wl ststements, the trustee5 a￿ required to
seject surtabk ￿cOUnting rKAKaes and then them C￿nsisten￿,.
serve the methc*Js and principlgs in the chanb.es SORP,"
make judgments and estsmates that are reasonable and wsdent..
stale whether apF4ublo UK Ac{￿nting Standards have followed. sutr4.ect to ariy
matenal departures dwkn&J and ewained in the finano81 statwnents",
prepare the financkAI statements on the'g(Mng ¢(H￿em, basis unless rt is inappropriate to
presume that the ¢hantabk cc¥npany will continue in business.
The trustees are resp￿S￿)le for keeping adequ#le aCc￿nb"ng record5 that disclose Y￿th reasonable
aeLura¢y at any tirne the financial p05thon of the charrtable company and group and enable them lo
ensure Ihal the financia5 statements compty with the Compan*s Act 20(￿, the Charities and Trustee
Investment {Scotlandl Act 2￿)5 and the Chaiiiies Ac£ounts Iscouandl RegulatK)n5 20[￿ las amended).
They are also responsible for safeguarding the assets ofthe charrtable company and the group and hen
for taking reasonable steps forthe prevention and delection of fraud and other irregularities.
The trustees are responsible for the Maintenan￿ and integrty ofthe corporate and finanaal information
included on tre chantable company's websrte. legisL4tk)n In the Unrted knngdom goveming the
preparatx)n and di%semInat￿ offinar￿1al statements may drffeT from legtslth.on in other jurisdictions.
Statement as to disclosure of infonnation to auditors
The Irustees who We￿ in Offi￿ on the date of approval of these finanaal statements have cDnfirmed. as
far as they are aware, that there is no relevant audit infomiation of which the audrtors are unaware. Each
ofthe trustees have confimied that they have taken all the steps that they ought to have taken as trustees
in order to make Ihemsefves of any rdevant audrt InfO￿￿knn aThJ to estabhsh that rt has been
c¢ynrnunKated to the auditors.
Auditors
The audrtors. ft•M UK Audit LLP, have indicated Iheir willirgrEss to UJntinu6 in tsffic¢.
Stsff
We would like to pay tribute to the staff of the F(xJnd*i(x) who euth'nue lo shtrw eonsider8ble enthusiasm
and conynitmenl.
Partnerts and supporters
We would 5ike lo record a sincere thanks to all our partners aNI supportws vtho We hdped the Charty in
any way this year.
Small Company Provlsions
This report has been prepared in a¢¢Lydance with the promsions applrable for ct¥ry>anie5 entit￿ to the
small companie5 exemptton.
By ord
of the trust
Max Stèinbefg CBE
Chaiman
20 S8ptemb8r 2021
31

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



Roy Castle Lung Cancer Foundation
INDEPENDENT AUtXTOR'S REPORT TO THE MEMBERS OF ROY CASTLE LUNG CANCER FOUNDATION
A further de5cripb.on ol our responsibilities for the audit of the financial statements is lo¢*ed on the Financial
Reporting Council's website at http".IthM.frc.org.uklauditorsreSponsibilit￿s. This Oescriplion foms part of our
audrtorfs report.
Use of our report
This report is made exclusivety lo the mernbets, as a b(%ty. in accordarKe wrth Chapter 3 of Part 16 of the
Companies Act 2006. and to the charilable company's trustees, as a b(xJy. in accordan￿ wrth section 4411 IIGI
of Ihe Charities and Trustee Investment Iscottandl Act 2005 and regulation 10 of the Charities Accounts
IS¢otland) Regvlalions 2006 las 3mended} and the Charities Act 2011. Our audit work has been undertaken
so that we might slate lo the members and Ihe charitable ccxnpany's trustees those matters we are required to
slate lo them in an audrtor's report and for no other purpose. To the fvllesl extent pem)rtled by law. we do not
accept or assume responsibility lo anyone other than the ¢haritab￿ company, ils members as a body, and rts
trustees as a body. for our audit worK for this rewrL or for the opillions we have fOrrr￿d.
Anna Spencer-Gray
For and on behalf of RSM UK AUDIT LLP, Ststutw Auditor
Chartered Accountants
20 Cliéipttl Slieel
Liverpool
L3 9AG
Date." 21 Septetnb8r 2021
RSM UK AUDIT LLP is eligible to act as an auditcK in lern￿ of 1212 of the C{mpan￿S Act 2006.
36

## 

## 

|**Consolidated**||||||
|---|---|---|---|---|---|
|||**Unrestricted**|**Restricted**|**Total**|**Total**|
||**Notes**|**Funds**|**Funds**|**Funds**|**Funds**|
|||**2020**|**2020**|**2020**|**2019**|
|||£|£|£|£|
|**Income & Endowmentsfrom:**||||||
|Donations&Legacies|10|1,021,123|684,741|1,705,864|2,053,059|
|Charitable activities|11|1,512|35,000|36,512|8,209|
|Other trading activities|12|1,323,553||1,323,553|2,699,657|
|Investments|13|32,237||32,237|38,387|
|Other|14|871,118|-1,302|872,420|6,026|
|**Totalincome**||**3,249,543**|**721,043**|**3,970,586**|**4,805,338**|
|**Expenditureon:**||||||
|Raising funds|15|2,559,637|72,381|2,632,018|2,807,197|
|Charitable activities|16|1,088,993|325,287|1,414,280|2,008,418|
|**Totalexpenditure**||**3,648,630**|**397,668**|**4,046,298**|**4,815,615**|
|Net gains on investments|27|17,608||17,608|116,107|
|**Net(expenditure)/income**||**(381,479)**|**323,375**|**(58,104)**|**105,830**|
|Net movementinfunds||(381,479)|323,375|(58,104)|105,830|
|**Reconciliation offunds:- **||||||
|**Totalfunds brought forward**||**722,707**|**473,652**|**1,196,359**|**1,090,529**|
|**Totalfunds carried forward**||**341,228**|**797,027**|**1,138,255**|**1,196,359**|





## 

## 

|**Charity Only**||||||
|---|---|---|---|---|---|
|||**Unrestricted**|**Restricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|**Funds**|
|||**2020**|**2020**|**2020**|**2019**|
||**Notes**|£|£|£|£|
|Donations &Legacies|18|967,188|684,741|1,651,929|2,452,549|
|Charitable activities|19|1,512|35,000|36,512|8,209|
|Other trading activities|20|275,877||275,877|96,114|
|Investments|21|33,072||33,072|39,762|
|Other|22|198,418|1,302|199,720|6,026|
|**Total income**||**1,476,067**|**721,043**|**2,197,110**|**2,602,660**|
|**Expenditure on:**||||||
|Raisingfunds|23|724,972|72,381|797,353|650,148|
|Charitable activities|24|1,163,009|325,287|1,488,296|1,954,246|
|**Totalexpenditure**||**1,887,981**|**397,668**|**2,285,649**|**2,604,394**|
|Net gains on investments|27|17,608||17,608|116,107|
|**Net(expenditure)/income**||**(394,306)**|**323,375**|**(70,931)**|**114,373**|
|Net movementinfunds||(394,306)|323,375|(70,931)|114,373|
|**Reconciliation of funds:-**||||||
|**Totalfunds brought forward**||**820,796**|**433,446**|**1,254,242**|**1,139,869**|
|**Totalfundscarriedforward**||**426,490**|**756,821**|**1,183,311**|**1,254,242**|





Roy Castle Lung Cancer Foundation
Company number.. 03059425
Consolidated Balance Sheet as at 31 December 2020
2020
2019
Notes
Fixed assèts
Tangible assets
Inveslrnents held as fixed assets
28
29
145.665
1.049.672
188,881
1,166,512
Total fixed assets
1,195.337
1,355.393
Current assets
Stock5
Debtors
Cash al bank and in hand
31
32
82,906
409,493
668,586
92,293
471,044
387,694
Total current assets
1,160,985
951,031
Creditors.. amounts falling due
within oné year
33
11,028,067)
(1,110,085)
Net current assetsllliabilitiesl
132.918
{159,0341
Total assets less current liabilities
1.328,255
1,196,359
Creditors.. amounts falling due
over one year
34
1190,0001
{190,0001
The total net assets of the group
1,138.255
1,196,359
The total net assets of the group arè fundèd by the funds of the charity, as follows-.
Restricted funds
Restricted Revenue Funds
40
797.027
473,652
Unrestricted Funds
Unreslricled Revenue Funds
40
341.228
722,207
Total group funds
1,138,255
1.196.359
The Trustees have prepared the group accounts in accordance with section 398 of the Companies Act 2006
and seclh)n 44 of the Charities and Trustees Investment IS¢ollandl Act 2QO5.
The direclois acknowledge their responsibilities for comptying with the requirements of the Companies Act
2006 with respect lo accounting records and the preparation of accounts.
The aceounls have been prepared in accordan￿ with the provisions in Part 15 of the Companies Act 2Q06
applicable to companies subject to the small companies regime.
Approved by the board of trust
s on 20 S8ptember2021 and signed on their behalf by..
Max Steinberg CBE
Trustee
The notes on pages 45 10 74 form an integral part of these financial ststements.
39

Roy Castle Lung Cancer Foundation
Company number.. 03059425
Charlty Only Balance Sheet as at 31 December 2020
2020
2019
Notes
Fixed asset5
Tangible assets
Investments held as fixed assets
28
29
39,883
1.179,267
60.563
1,296,107
Total fixed assets
1,219.150
1.356,670
Current assets
Stocks
Debtors
Cash al bank and in hand
31
32
13,769
475,601
528,062
12,722
627.765
244,589
Total current assets
1,017.432
885,076
Creditors.. amounts falling due
within one year
33
(863,2711
1987,5041
Net current assetsllliabllitiesl
154,161
1102,428)
Total assets less current liabilities
1,373,311
1,254,242
Creditors.. amounts falling duè
Ovor ong year
34
{190,0001
1190,000)
The total net assets of the charlty
1,183,311
1,254,242
The total net assets of the charity are funded by the funds of the charity. as follows:.
Restricted funds
Restricted Revenue Funds
40
756.821
433,446
Unrestrlcted Funds
Unrestricted Revenue Funds
40
426,490
820,796
Total charlty funds
1,183,311
1,254.242
The Trustees have prepared the group accounts In accordance with section 398 of the Companies Act 2006
and section 44 of the Chaiilies and Trustee5 Investment (Scotlandl Act 2005.
The diredors a¢knowSedge their responsibilities for complying with the requirements of the Companies Act
20{￿ with respect to accounting records and the preparation of accounts.
The aecounts have been prepared in accordance with the provisions in Part 15 ofthe Companies Act 2006
applicable lo companies subject lo the small cornpanies regime.
Approved by the board of trustees on 20 September 2021 and signed on their behalf by..
Max Sleinl)erg CBE
Trustee
The notes on pages 45 10 74 foFm an integral part of these financial slalernenls.
40

## 

||**2020**|**2019**||
|---|---|---|---|
||£|£||
|**Cashflows from operating activities**||||
|Net cash usedinoperating activities as shown||||
|below|(70,686)|(78,870)||
|**_Cashflowsfrominvesting activities_**||||
|Interest received|442|4,777||
|Dividends received|28,195|33,184||
|Other investmentincome,including rents from investments|3,600|1,336||
|Purchase ofproperty,plant and equipment|(15,107)|(97,581|)|
|Receipts from sale of tangible fixed assets||1,092||
|Proceeds from sales of investments|178,387|95,156||
|Purchase of investments|(85,020)|(156,036)||
|Increaseincash heldforinvestment|41,081|28,816||
|**Net cash used ininvesting activities**|151,578|(86,256)||
|**_Cashflowsfromfinancing activities_**||||
|Proceeds of new short-term borrowings|10,000|||
|Proceeds of newlong-term borrowings|190,000|||
|**Net cash used infinancing activities**|200,000|||
|**Net increase/(decrease)**<br>**in cash and cashequivalents**|280,892|(165,126)||
|**Reconciliation ofnet cashflowtomovementin netfunds**||||
|Net cash at1January 2020|387,694|552,820||
|Increaseincashinthe period|280,892|(165,126)||
|Cash inflow from increaseindebt financing|(200,000)|||
|**Net cash at31December 2020**|468,586|387,694||
||**2020**|**2019**||
||£|£||
|**Reconciliationofnet income to net cashflowfrom operating activities**||||
|Net(expenditure)/income showninthe Statement of Financial Activities|(58,104)|105,830||
|**_Adjustments for:-_**||||
|Depreciation charges|58,323|66,083||
|Net changeoninvestment assets|(17,608)|(116,107)||
|Dividends,interest and rents from investments|(32,237)|(39,297)||
|Decrease/(increase)instocks|9,387|(12,084)||
|Decrease/(increase)indebtors|61,551|(68,109)||
|Decreaseincreditors|(91,998)|(15,186)||
|**Net cash used inoperating activities**|**(70,686)**|**(78,870)**||
||||41|





## 

||**2020**|**2019**|
|---|---|---|
||£|£|
|**Analysis ofcash and cashequivalents**|||
|Cashinhand at for the year ended31December 2020|668,586|387,694|
|Loans for the year ended31December 2020|(200,000)||
|**Total cash and cashequivalents**|**468,586**|**387,694**|
|||--|





## 

||**2020**|**2019**|
|---|---|---|
|**Cashflowsused in operatingactivities**|£|£|
|Net cash usedinoperating activities as shown|||
|below|(81,227)|(28,038)|
|**_Cashflowsusedin investing activities_**|||
|Interest received|1,277|4,777|
|Dividends received|28,195|33,184|
|Other investment income,including rents from investments|3,600|1,800|
|Purchase ofproperty,plant andequipment|(2,820)|(29,366)|
|Proceeds from sales ofinvestments|219,468|123,972|
|Purchase of investments|(85,020)|(153,036)|
|**Net cash used ininvesting activities**|164,700|(18,669)|
|**_Cashflowsfromfinancing activities_**|||
|Net movementinshort term borrowings|10,000||
|Net movementinlong term borrowings|190,000||
|**Net cash used infinancing activities**|200,000||
|**Net increase/(decrease)**<br>**in cash and cashequivalents**|283,473|(43,707)|
|**Reconciliation ofnet cashflowto movement in netfunds**|||
|Net cash at1January 2020|244,589|288,296|
|Increaseincashinthe period|283,473|(43,707)|
|Cashinflow from increaseindebtfinancing|(200,000)||
|**Net cash at31December 2020**|328,062|244,589|
||**2020**|**2019**|
||£|£|
|**Reconciliationofnet income to net cashflowfrom operating activities**|||
|Net(expenditure)/income showninthe Statement of FinancialActivities|(70,931)|114,373|
|**_Adjustments for:-_**|||
|Depreciation charges|23,500|25,457|
|Net change on investment assets|(17,608)|(116,107)|
|Dividends,interest and rents from investments|(33,072)|(39,761)|
|Decrease/(Increase)instocks|(1,047)|(4,651)|
|Decrease/(Increase)indebtors|152,164|(263,413)|
|(Decrease)/Increaseincreditors|(134,233)|259,064|
|**Net cash used by operatingactivities**|**(81,227)**|**(25,038)**|





## 

||**2020**|**2019**|
|---|---|---|
||£|£|
|**Analysis ofcash and cashequivalents**|||
|Cashinhand at for the year ended31December 2020|528,062|244,589|
|Loans for the year ended31December 2020|(200,000)||
|**Total cash and cashequivalents**|**328,062**|**244,589**|





## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|Leasehold premises|over the length of the lease|
|---|---|
|Fixtures and Fittings|over the length of the lease|
|Research,office and computer equipment|between10%and25%|



## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|||**2020**|**2019**|
|---|---|---|---|
|||£|£|
||The net income/(expenditure)before taxinthe financial yearis|||
||stated aftercharging:-|||
||Depreciation of fixed assets|58,323|66,083|
||Operating leases|596,558|547,916|
|||**=======**|**-------**<br>**------- **|
||**Fees payable to thegroup'sauditor:**|**2020**|**2019**|
|||£|£|
||**Forauditservices**|||
||Audit of thefinancial statements of the group and charity|28,875|19,250|
|||**28,875**|**19,250**|
|||**-------**<br>**------- **|**=======**|
||Taxation compliance services|2,750|3,975|
||All othernon-audit services|11,550|7,725|
|||**15,644**|**11,700**|
|||**-------**<br>**-------**|**=======**|
|6|**Interest payable**|**2020**|**2019**|
|||£|£|
||Bank interest payable|807|757|
|||**807**|**757**|
|||**------- **<br>**-------**|**-------**<br>**-------**|



## 

## 

||**Group**|**Group**|**Charity**|**Charity**|
|---|---|---|---|---|
||**2020**|**2019**|**2020**|**2019**|
||£|£|£|£|
|Grosssalaries|1,955,953|2,049,547|1,097,639|1,106,621|
|Employer's National Insurance|130,122|140,612|92,203|95,891|
|Employer'sPension|45,462|46,129|32,470|32,514|





## 

## 

|||**2020**||**2019**|
|---|---|---|---|---|
|||£||£|
|Engaged on charitable activities||18||25|
|Engaged on fundraising activities||19||16|
|Engaged on management and administration||13||10|
|Engaged onretailactivities||77||86|
|||**127**||**138**|
||**-------**<br>**-------**||**-------**<br>**-------**||



|contributions fall into the following bands were:-|||
|---|---|---|
||**2020**|**2019**|
||£|£|
|£60,001 to £70,000|||
|£70,001 to£80,000|||
|(Group and charity)|||
||1|1|
|||**-------**<br>**------_**|
||**2020**|**2019**|
|Chief Executive_Officer/_Highest paid employee|£|£|
|The remunerationinthe year was|70,725|69,000|
|Pension contributions paid by the employer|4,390|4,235|
|**_Totalremunerationpackageincludedintotal salariesabove_**|**75,115**|**73,235**|
||**=======**||



## 



## 

|**10**|**Donations and Legacies- Consolidated**|**Unrestricted**|**Restricted**|**Total**|**Total**|
|---|---|---|---|---|---|
|||**Funds**|**Funds**|**Funds**|**Funds**|
|||**2020**|**2020**|**2020**|**2019**|
|||£|£|£|£|
||**Donations andgiftsfromindividuals**|||||
||Donations|9,491||9,491|<br>13,771|
||Individual Giving|374,074|1,662|<br>375,736|397,593|
||Payroll Giving|105,126||105,126|115,886|
|||488,691|1,662|490,353|527,250|
||**Legacies receivable**|||||
||Legacies receivable|168,315||168,315|479,412|
|||657,006|1,663|658,668|1,006,662|
||**Revenue grants and donations fromnon-public**|**bodies**||||
||Corporate Grants|59,604||59,604|131,294|
||Trusts|34,375|211,933|246,308|129,878|
|||93,979|211,933|305,912|261,172|
||**Sponsorship**|||||
||Pause for Hope||1,293|1,293|5,872|
||Sponsorship|16,937|469,113|486,050|378,347|
|||16,937|470,406|487,343|384,219|
||**In Memoriam**|||||
||InMemoriam|168,525|740|169,265|187,012|
|||168,525|740|169,265|187,012|
||**Gift Aid on Donations**|||||
||Gift Aid on Donations|84,676||84,676|213,994|
|||84,676||84,676|213,994|
||**Total Donations and Legacies- Consolidated**|**1,021,123**|**684,741**|**1,705,864**|**2,053,059**|
|||**-------**<br>**-------**|**-------**<br>**------- **|**-------**<br>**-------**|------<br>**-------**|





## 

## 

||**Unrestricted**|**Restricted**|**Total**|**Total**|
|---|---|---|---|---|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||£|£|£|£|
|**Charitable income fromfunders**|||||
|Community engagement|1,512|35,000|36,512|36,512|
||1,512|35,000|36,512|36,512|
|**Reimbursement**|||||
|Minor reimbursed expenses andhonoraria||||8,209|
|||||8,209|
|**Total income from charitableactivities**|**1,512**|**35,000**|**36,512**|**8,209**|
||**---------**<br>**---------**|**---------**<br>**---------**|**---------**<br>**---------**|**=======**|



## 

||**Unrestricted**|<br>**Restricted**|<br>**Restricted**|<br>**Total**|**Total**|
|---|---|---|---|---|---|
||**Funds**|**Funds**||**Funds**|**Funds**|
||**2020**|**2020**||**2020**|**2019**|
||£|£||£|£|
|Trading activities toraise funds|8,528|||8,528|<br>30,490|
|Income from íundraisinq events|322,698|||322,698|50·1,302|
|Income from the sale of donated and broughtingoods|<br>983,668|||983,668|2,160,630|
|Sponsorships and social lotteries which cannot be||||||
|considered pure donations|8,659|||8,659|<br>7,235|
||**1,323,553**||**-**|**1,323,553**|<br>**2,699,657**|
||**--------**<br>**--------**|**=======**|**========**||**========**|





## 

## 

|**Investmentincome - Consolidated**|||||
|---|---|---|---|---|
||**Unrestricted**|**Restricted**|<br>**Total**|**Total**|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||`£`|`£`|£|£|
|Property Rental Income|3,600||3,600|1,337|
|DividendIncome|28,195||28,195|33,184|
|Bank InterestReceivable|442||422|<br>3,866|
||**32,237**||**32,237**|**38,386**|
||**------- **<br>**-------**|**------- **<br>**-------**|**-------**<br>**-------**|**------- **<br>**-------**|



## 

|**Other - Consolidated**|||||
|---|---|---|---|---|
||**UnrestrictedRestricted**||<br>**Total**|**Total**|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||`£`|`£`|£|£|
|Consultancyandadvice|24,396|1,302|25,698|6,026|
|Coronavirusgrant income|834,285||834,285||
|Otherincome|12,437||12,437||
||**871,118**|**1,302**|**872,420**|**6,026**|
||**======= **|**------- **<br>**-------**|**-------**<br>**---_---**|**-------**<br>**-------**|



## 

||**UnrestrictedRestricted**|**UnrestrictedRestricted**|<br>**Total**|**Total**|
|---|---|---|---|---|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||£|£|£|£|
|Costoffund raising activities|37,139|12,500|49,639|39,527|
|Marketing & advertising of fundraising|56,118|25,526|81,644|16,999|
|Costs ofseekingdonations,grants andlegacies|144||144|<br>362|
|Cost of operating sociallotteries|1,508||1,508|1,558|
|Costsofstagingfundraising events|104,539|12,392|116,931|112,685|
|Costs ofcharity shop selling goods|1,799,763|-|1,799,763|2,036,418|
|Gross wages andsalaries-fund raising activities|393,384|5,787|399,171|406,483|
|OtherDirect Costs - fundraising Activities|162,924|15,921|178,845|177,609|
|Staff Training &Welfare -fundraising Activities|2,324||2,324|3,533|
|TravelandSubsistence -fundraisingActivities|1,794|256|2,050|12,023|
||**2,559,637**|**72,381**|**2,632,018**|**2,807,197**|
||**============== **||**------- **<br>**-------**|**-------**<br>**-------**|





## 

|**16**|**Expenditure on charitableactivities- Consolidated**|**Expenditure on charitableactivities- Consolidated**||||||
|---|---|---|---|---|---|---|---|
||||**Staff**|||**Total**|**Total**|
||||**Costs**||**Other**|**Funds**|**Funds**|
|||**Note**|**2020**||**2020**|**2020**|**2019**|
||||£||£|£|£|
||**Direct spending**|||||||
||Restricted||43,839|157,284||201,123|295,957|
||Unrestricted||229,281||57,971|287,252|400,734|
||||273,120|215,255||488,375|696,691|
||**Grantfunding**|||||||
||Organisation grants|26|||78,584|78,584|401,430|
||Staff costs||29,800|||29,800|31,679|
||||29,800||78,584|108,384|433,109|
||**Support costs**(allunrestricted)|||||||
||Staff costs||569,823|||569,823|596,453|
||Premises costs||||82,273|82,273|63,492|
||Legal andprofessional costs||||13,164|13,164|35,205|
||Financial||||45,882|45,882|41,739|
||Other||||32,050|32,050|105,729|
||||569,823|173,369||743,192|842,618|
||**Governancecosts:**|||||||
||Audit fees||||42,495|42,495|23,100|
||Accountancy fees||||31,834|31,834|12,900|
||||**872,743**|**541,537**||**1,414,280**|**2,008,418**|
||||**-------**<br>**-------**|**-------**<br>**-_-----**||**-------**<br>**-------**|**-------**<br>**-------**|



## 

||||**Grant**||||
|---|---|---|---|---|---|---|
||**Direct**|**Support**|**funding**|**Governance**|**Total**|**Total**|
||**costs**|**costs**|**of activities**||**2020**|**2019**|
|Research|165,567|267,549|108,384|26,758|568,258|1,100,961|
|Support|321,448|193,230||19,326|534,004|570,675|
|Prevention|1,360|282,413||28,245|312,018|336,782|
||**488,375**|**743,192**|**108,384**|**74,329**|**1,414,280**|**2,008,418**|
||**---------**<br>**------- **|**---------**<br>**-------- **|**-------**<br>**-------**|**------**<br>**------**|**-------**<br>**-------**|**--------**<br>**--------**|





## 

|**18**|**Donations and Legacies- Charity only**|||||
|---|---|---|---|---|---|
|||U**nrestricted**|<br>**Restricted**|<br>**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|**Funds**|
|||**2020**|**2020**|**2020**|**2019**|
|||£|£|£|£|
||**Donations andgiftsfromindividuals**|||||
||Donations|2,000||2,000||
||Individual Giving|374,072|1,663|375,735|397,593|
||Payroll Giving|105,126||105,126|115,886|
|||481,198|1,663|482,861|513,479|
||**Legacies receivable**|||||
||Legacies receivable|168,315||168,315|479,412|
|||168,315||168,315|479,412|
||**Revenue grants anddonationsfromnon-publicbodies**|||||
||Corporate Grants|59,604||59,604|131,294|
||Trusts|34,375|211,933|246,308|129,878|
|||93,979|211,933|305,912|261,172|
||**Sponsorship**|||||
||Pause for Hope||1,293|1,293|5,872|
||Sponsorships|13,437|469,113|482,550|371,756|
|||13,437|470,406|483,843|377,369|
||**In Memoriam**|||||
||InMemoriam|166,237|740|166,977|183,474|
|||166,237|740|166,977|183,474|
||**Gift Aid on Donations**|||||
||Gift Aid on Donations|44,021||44,021|637,643|
|||44,021||44,021|637,643|
||**Total Donations and Legacies - Charity**|**967,187**|**684,742**|**1,651,929**|**2,452,549**|
|||**---------**<br>**---------**|**---------**<br>**---------**|**---------**<br>**---------**|**---------**<br>**---------**|





## 

## 

||**Unrestricted**<br>**Restricted**|**Unrestricted**<br>**Restricted**|**Total**|**Total**|
|---|---|---|---|---|
||**Funds**<br>**Funds**||**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
|**Charitable income fromfunders**|||||
|Community engagement|1,512|35,000|36,512||
||1,512|35,000|36,512||
|**Reimbursement**|||||
|Minor reimbursed expenses and honoraria||||8,209|
|||||8,209|
|**Total income from charitableactivities**|**1,512**|**35,000**|**36,512**|**8,209**|
|Total income from charitable activities all related|to prevention.All|of 2019 income wasunrestricted.|||
|**Income from other,non-charitable, tradingactivities- Charityonly**|||||
||**Unrestricted**|<br>**Restricted**|<br>**Total**|**Total**|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||£|£|£|£|
|Income from fund raising events|267,293||267,293|89,726|
|Sponsorships and social lotteries which cannot|||||
|be considered pure donations|8,584||8,584|6,388|
||**275,877**||**275,877**|**96,114**|
||**-------**<br>**-------**|**-------**<br>**------- **|**------- **<br>**-------**|**-------**<br>**-------**|



## 

## 

|**Investment income- Charity Only**|||||
|---|---|---|---|---|
||**Unrestricted**|<br>**Restricted**|<br>**Total**|**Total**|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||£|£|£|£|
|Property Rental Income|3,600||3,600|1,801|
|Dividend Income|28,195||28,195|33,184|
|BankInterest Receivable|1,277||1,277|4,777|
||**33,072**||**33,072**|**39,762**|
||**-------**<br>**-------**|**------- **<br>**-------**|**-------**<br>**-------**|**=======**|





## 

## 

|**Other - Charity**|||||
|---|---|---|---|---|
||**UnrestrictedRestricted**||<br>**Total**|**Total**|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||£|£|£|£|
|Consultancy and advice|24,396|1,302|25,698|6,026|
|Coronavirus grant income|161,585||161,585||
|Other income|12,437||12,437||
||**198,418**|**1,302**|**199,720**|**6,026**|
||**=======**|**-------**<br>**-------**|**-------**<br>**------_ **|**-------**<br>**-------**|



## 

||**UnrestrictedRestricted**|**UnrestrictedRestricted**|<br>**Total**|**Total**|
|---|---|---|---|---|
||**Funds**|**Funds**|**Funds**|**Funds**|
||**2020**|**2020**|**2020**|**2019**|
||`£`|`£`|£|£|
|Cost of fundraising activities|18,526|12,500|31,026|16,210|
|Marketing&advertising of fund raising|56,118|25,525|81,643|16,999|
|Costs of seekingdonations,grants and legacies|144||144|<br>362|
|Cost of operating social lotteries|1,508||1,508|1,558|
|Costs of staging fundraising events|93,912|12,392|106,304|23,641|
|Gross wages and salaries - fundraising activities|393,383|5,787|399,170|406,483|
|Other Direct Costs - Fundraising Activities|157,263|15,921|173,184|169,339|
|_Staff_Training&Welfare - Fundraising Activities|2,324||2,324|3,533|
|Travel and Subsistence - Fundraising Activities|1,794|256|2,050|12,023|
||**724,972**|**72,381**|**797,353**|**650,148**|
||**-------**<br>**-------**|**-------- **<br>**-------**|**-------**<br>**-------_ **|**-------**<br>**-------**|





## 

## 

|||**Staff**||**Total**|**Total**|
|---|---|---|---|---|---|
|||**costs**|**Other**|**Funds**|**Funds**|
||**Note**|**2020**|**2020**|**2020**|**2019**|
|||£|£|£|£|
|**Direct spending**||||||
|Restricted||43,839|157,284|201,123|295,957|
|Unrestricted||229,281|56,611|285,892|393,434|
|||273,120|213,895|487,015|689,391|
|**Grant funding**||||||
|Organisation grants|26||78,584|78,584|401,430|
|Staff costs||29,800||29,800|31,679|
|||29,800|78,584|108,384|433,109|
|**Support costs**||||||
|Staff costs||569,823||569,823|596,453|
|Premises costs|||82,273|82,273|63,492|
|**Legal**and professional costs|||13,164|13,164|35,205|
|Depreciation/interest|||25,880|25,880|867|
|Other - admin|||136,731|136,731|105,729|
|||569,823|258,048|827,871|801,746|
|**Governancecosts:**||||||
|Audit fees||42,495||42,495|19,250|
|Accountancy fees||22,531||22,531|10,750|
|||**937,769**|**550,527**|**1,488,296**|**1,954,246**|
|||**-------**<br>**-------**|**=======**||**-------**<br>**-------**|



## 

||||**Grant**||||
|---|---|---|---|---|---|---|
||**Direct**|**Support**|**funding**|**Governance**|<br>**Total**|**Total**|
||**costs**|**costs**|**of activities**||**2020**|**2019**|
|Research|165,567|298,034|108,384|23,409|595,394|1,084,361|
|Support|321,448|215,246||16,907|553,601|557,980|
|Prevention||314,591||24,710|339,301|<br>311,905|
||**487,015**|**827,871**|**108,384**|**65,036**|**1,488,296**|**1,954,246**|
||||**-------**<br>**------- **|**-------**<br>**-------**|**`=========`**|**=========**|





## 

## 

||**UnrestrictedRestricted**|**UnrestrictedRestricted**||**Total**|**Total**|
|---|---|---|---|---|---|
||**Funds**|**Funds**|**Funds**||**Funds**|
||**2020**|**2020**||**2020**|**2019**|
||£|£||£|£|
|University of Liverpool||2,500||2,500|39,234|
|University College London|||||145,566|
|Community Engagement ResearchProgramme||6,249||6,249||
|University of Nottingham|14,044|||14,044|49,874|
|Leeds|||||24,991|
|Manchester CancerResearch Centre|9,600|191||9,791||
|Wessex Cancer Alliance&Southampton|||||65,000|
|BiblimetricResearch||26,000|26,000||26,000|
|SocialMediaResearch|20,000|20,000|50,765|||
||**23,644**|**59,940**|**78,584**||**401,430**|
||**------- **<br>**-------**|**-------**<br>**------- **|**-------**<br>**---_---**||**-------**<br>**-------**|



|**27**|**Investment gains**|||||
|---|---|---|---|---|---|
|||**Unrestricted**|<br>**Restricted**|<br>**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|**Funds**|
||**Group**|**2020**|**2020**|**2020**|**2019**|
|||£|£|£|£|
||Listedinvestments-Realisedgains|34,523||34,523|24,489|
||Listed investments-Unrealised(Iosses)/gains|(16,915)||(16,915)|91,618|
||**Total realised and unrealisedgains**|**17,608**||**17,608**|**116,107**|
|||**-------**<br>**-------**|**------- **<br>**-------**|**-------**<br>**-------**|**-------**<br>**-------**|



||U**nrestricted**|**Restricted**|**Total**|**Total**|
|---|---|---|---|---|
||**Funds**|**Funds**|**Funds**|**Funds**|
|**Charity Only**|**2020**|**2020**|**2020**|**2019**|
||£|£|£|£|
|Listed investments-Realised gains|34,523||34,523|24,489|
|Listed investments-Unrealised (Iosses)/gains|(16,915)||(16,915)|91,618|
|**Total realised and unrealised gains**|**17,608**||**17,608**|**116,107**|
||**=======**|**-------**<br>**-------**|**-------**<br>**-------**|**-------**<br>**-------**|





## 

|**28**|**Tangible fixed assets**|||**Research**||
|---|---|---|---|---|---|
|||**Leasehold**|**Fixtures**|**officeand**||
||**Group**|**land and**|**and**|**computer**|**Group**|
|||**buildings**|**fittings**|**equipment**|**total**|
|||£|£|£|£|
||**Cost**|||||
||At1January 2020|589,981|309,216|469,671|1,368,868|
||Additions|392|10,944|3,771|15,107|
||**At31December 2020**|**590,373**|**320,160**|**473,442**|**1,383,975**|
||**Depreciation**|||||
||At1January 2020|557,714|212,333|409,940|1,179,987|
||Charge for the year|5,590|24,868|27,865|58,323|
||**At31December 2020**|**563,304**|**237,201**|**437,805**|**1,238,310**|
||**Net book value**|||||
||At31December 2020|27,069|82,959|35,637|145,665|
||At31December 2019|32,267|96,883|59,731|188,881|



||||**Research**||
|---|---|---|---|---|
||**Leasehold**|**Fixtures**|**officeand**||
|**Charity Only**|**land and**|**and**|**computer**||
||**buildings**|**fittings**|**equipment**|**Total**|
||£|£|£|£|
|**Cost**|||||
|At1January 2020|6,783|43,844|341,394|392,021|
|Additions|||2,820|2,820|
|**At31December 2020**|**6,783**|**43,844**|**344,214**|**394,841**|
|**Depreciation**|||||
|At1January 2020|3,522|26,048|301,888|331,458|
|Charge for the year|785|6,110|16,605|23,500|
|**At31December 2020**|**4,307**|**32,158**|**318,493**|**354,958**|
|**Net book value**|||||
|At31December 2020|2,476|11,686|25,721|39,883|
|At31December 2019|3,261|17,796|39,506|so.sss|





## 

## 

||**Investmentsin**|**Listed**||
|---|---|---|---|
||**Subsidiary**|**investments**||
||**undertakings**||**Total**|
||£|£|£|
|**Carryingvaluesof investments**||||
|At1January 2020|129,595|1,166,512|1,296,107|
|Additions||85,020|85,020|
|Cash movement||(41,081)|(41,081)|
|Disposals||(143,864)|(143,864)|
|Revaluation at31December 2020||(16,915)|(16,915)|
|**At31December 2020**|**129,595**|**1,049,672**|**1,179,267**|



## 

|Investments as above historical cost|129,595|786,766|1,016,201|
|---|---|---|---|
|**Analysis of types of investments:**||||
|||**2020**|**2019**|
|Cash||82,822|123,901|
|Listed investments||966,850|1,042,611|
|||**1,049,672**|**1,166,512**|



||**Includedat**|
|---|---|
||**Historical**|
||cost,**less**|
||**write down**|
||£|
|Loans to group undertakings|129,592|
|Equity investmentingroup undertakings|3|
||129,595|
|**Analysis of equity investments:**||
|Investments cost|3|
||3|



|**Company**|**Shares held**|**Direct**|
|---|---|---|
||Class|%|
|Cut Films Limited|Ordinary|**100**|
|Roy Castle Retail Limited|Ordinary|**100**|
|Roy Castle Trading Limited|Ordinary|**100**|





## 

## 

## 

|||2020|2019|
|---|---|---|---|
|||£|£|
|_Assetsand Funds_||||
|Aggregate amount of assets||584,930|628,425|
|Aggregate amounts of liabilities||(910,2131)|(929,637)|
|Aggregate amount of funds||(325,201)|(301,212)|
|||--------<br>--------|--------<br>--------|
|_ProfitandLoss_||||
|Turnover net of VAT||1,084,576|2,704,205|
|Expenses net of VA T||(1,119,575)|(2,208,175)|
|_NetprofIt fortheyearbefore tax_||(34,999)|496,030|
|Interest Paid||(835)|(911)|
|Gift Aid Payments made to holding company||(3,223)|(534,156)|
|_Netloss fortheyear aftertax andgift aid_||(39,057)|(39,037)|
|||========|--------<br>--------|
||Note|2020|2019|
|||£|£|
|Restricted funds retained within charitable subsidiaries|40|40,208|40,208|
|||========|--------<br>--------|





## 

|**31**|**Stock**||**Group**||**Charity**|**Only**|
|---|---|---|---|---|---|---|
|||**2020**||**2019**|**2020**|**2019**|
|||`£`||`£`|`£`|`£`|
||Stocks|82,906||92,293|13,769|12,722|
|||**82,906**||**92,293**|**13,769**|**12,722**|



## 

|**_Analysis_of****_the value_of****_stock by activity_**|||||
|---|---|---|---|---|
|||**Group**|**Charity**|**Only**|
||**2020**|<br>**2019**|**2020**|**2019**|
||`£`|`£`|`£`|`£`|
|**_Activity_**|||||
|Fundraising activities|13,769|12,722|13,769|12,722|
|Stocks for Sales of donated and related Goods|69,137|79,571|||
||**82,906**|<br>**92,293**|**13,769**|**12,722**|
|**Debtors**||**Group**|**Charity**|**Only**|
||**2020**|<br>**2019**|**2020**|**2019**|
||£|£|£|£|
|Trade debtors|93,423|<br>78,997|44,162|20,513|
|Amounts owed by group undertakings and|||||
|undertakingsinwhich the company hasa|||||
|participating interest|||273,868|425,235|
|Prepayments and accrued income|254,283|354,916|134,243|167,569|
|Other debtors|61,787|37,131|23,328|14,448|
||**409,493**|<br>**471,044**|**475,601**|**627,765**|



## 



## 

||||**Group**|**Charity**|**Only**|
|---|---|---|---|---|---|
||**Note**|**2020**|<br>**2019**|**2020**|**2019**|
|||`£`|`£`|`£`|`£`|
|Trade creditors||113,148|192,526|80,509|154,463|
|Accruals and deferred income|35|384,965|233,884|267,882|147,031|
|PAYE,NIC VAT and other taxes||41,319|45,767|41,319|45,767|
|Bank loan||10,000||10,000||
|Other creditors||478,635|637,888|463,561|640,245|
|||**1,028,067**|<br>**1,110,065**|**863,271**|**987,506**|



|**more than oneyear**||**Group**||**Charity**|**Only**|
|---|---|---|---|---|---|
||**2020**||**2019**|**2020**|**2019**|
||£||£|`£`|`£`|
|Bank loan|190,000|||190,000||
||**190,000**|||**190,000**||



## 

||**Group**|**Charity only**|
|---|---|---|
||**2020**|**2020**|
||£|£|
|Brought forward|31,960|31,960|
|Deferredinthe year|96,031|96,031|
|Amounts releasedinthe year|(31,960)|(31,960)|
|Carried forward|**96,031**|**96,031**|





## 

|**36**|**Analysis ofchanges in net cash**|||||
|---|---|---|---|---|---|
||**Group**|||**Market value**||
|||**01/01/2020**|**Cashflows**|**movements**|**31/12/2020**|
|||£|£|£|£|
||**Net Cash**|||||
||Cash at bank andinhand|387,694|280,892||668,586|
|||**387,694**|**280,892**||**668,586**|
||**Debt**|||||
||Debts falling due within one year||(10,000)||(10,000)|
||Debts falling due after one year||(190,000)||(190,000)|
||||**(200,000)**||**(200,000)**|
||**Netdebt**|**387,694**|**80,892**||**468,586**|
||**Charity**|||**Market value**||
|||**01/01/2020**|**Cashflows**|**movements**|**31/12/2020**|
|||£|£|£|£|
||**Net Cash**|||||
||Cash at bank andinhand|244,589|283,473||528,062|
|||**244,589**|**283,473**||**528,062**|
||**Debt**|||||
||Debts falling due within one year||(10,000)||(10,000)|
||Debts falling due after one year||(190,000)||(190,000)|
||||**(200,000)**||**(200,000)**|
||**Net debt**|**244,589**|**83,473**||**328,062**|





## 

## 

|**At the year end the group hadtotal outstandingcommitments**|**under**|**2020**|**2019**|
|---|---|---|---|
|**non-cancellable operating leases as setoutbelow:**||£|£|
|Operating leaseswhichexpire:||||
|within one year||580,058|531,416|
|within two to five years||1,352,594|1,411,373|
|inover five years||324,000|475,750|
|||2,256,652|2,418,539|
|**At the year end thecharityhadtotal outstandingcommitments**|<br>**under**|**2020**|**2019**|
|**non-cancellable operating leases as setoutbelow:**||£|£|
|Operating leases whichexpire:||||
|within one year||75,508|67,616|
|within two tofive years||159,694|187,848|
|||235,202|255,464|



## 

||**2020**|**2019**|
|---|---|---|
||£|£|
|Includedindebtors:|273,868|425,235|
|Inr.lurledinc::reditors:|||
|Interest charged on balances:|835|911|
|||**-----_**<br>**------ **|



## 



## 

## 

|**_Group_**||||
|---|---|---|---|
||U**nrestricted**|**Restricted**|**Total**|
|**_At_31****_December 2020_**|**funds**|**funds**|**funds**|
||£|£|£|
|Tangible Fixed Assets|145,665||145,665|
|Fixed asset investments|1,049,672||1,049,672|
|Current Assets|363,958|797,027|1,160,985|
|Current Liabilities|(1,028,067)||(1,028,067)|
|Non-current Liabilties|(190,000)||(190,000)|
||**341,228**|**797,027**|**1,138,255**|
|**Charity**|U**nrestricted**|**Restricted**|**Total**|
|**At31December 2020**|**funds**|**funds**|**funds**|
||£|£|£|
|Tangible Fixed Assets|39,883||39,883|
|Fixed asset investments|1,179,267||1,179,267|
|Current Assets|260,611|756,821|1,017,432|
|Current Liabilities|(863,271)||(863,271)|
|Non-current Liabilties|(190,000)||(190,000)|
||**426,490**|**756,821**|**1,183,311**|
|**_Group_**||||
||**Unrestricted**|**Restricted**|**Total**|
|**_At_31****_December 2019_**|**funds**|**funds**|**funds**|
||£|£|£|
|Tangible Fixed Assets|188,881||188,881|
|Fixed asset investments|1,166,512||1,166,512|
|Current Assets|477,379|473,652|951,031|
|Current Liabilities|(1,110,065)||(1,110,065)|
||**722,707**|**473,652**|**1,196,359**|
|**Charity**|**Unrestricted**|**Restricted**|**Total**|
|**At31December 2019**|**funds**|**funds**|**funds**|
||£|£|£|
|Tangible Fixed Assets|60,563||60,563|
|Fixed asset investments|1,296,107||1,296,107|
|Current Assets|451,630|433,446|885,076|
|Current Liabilities|(987,504)||(987,504)|
||**820,796**|**433,446**|**1,254,242**|





## 

|**Group**|**Funds**|||**Funds**|
|---|---|---|---|---|
||**brought**|||**carried**|
||**forward**|**Income**|**Expenditure**|**forward**|
||**2020**|||**2020**|
||£|£|£|£|
|**_Unrestrictedanddesignated funds:-_**|||||
|Group Unrestricted Funds|722,707|3,249,543|(3,631,022)|341,228|
|**Total unrestricted and designatedfunds**|**722,707**|**3,249,543**|**(3,631,022)**|**341,228**|
|**Charity Restricted Funds**|||||
|Sundry RCF Restricted Reserves|186,992|328,278|(183,728)|331,542|
|GLCC|246,998|392,765|(213,940)|425,823|
|Boehringer Ingleheim Awareness Project|(546)|||(546)|
|**Subidiary**|||||
|**Restricted Funds**|||||
|Cut Films Restricted Reserves|40,208|||40,208|
|**Total restricted funds**|**473,652**|**721,043**|**(397,668)**|**797,027**|
|**Total Group Funds**|**1,196,359**|**3,970,586**|**(4,028,690)**|**1,138,255**|



## 

|**Charity only**|**Funds**|||**Funds**|
|---|---|---|---|---|
||**brought**|||**carried**|
||**forward**|**Income**|**Expenditure**|**forward**|
||**2020**|||**2020**|
|**_Unrestrictedanddesignated funds:-_**|£|£|£|£|
|Unrestricted revenue funds|820,796|1,476,067|(1,870,373)|426,490|
|**Total unrestricted and designatedfunds**|**820,796**|**1,476,067**|**(1,870,373)**|**426,490**|
|**_ReF Restrictedfunds:- _**|||||
|Research-GLCC|246,998|392,765|(213,940)|425,823|
|Research-others|186,448|328,278|(183,728)|330,998|
|**Total restricted funds**|**433,446**|**721,043**|**(397,668)**|**756,821**|
|**Total Charity Funds**|**1,254,242**|**2,197,110**|**(2,268,041) **|**1,183,311**|





## 

|**Group**|**Funds**|||**Funds**|
|---|---|---|---|---|
||**brought**|||**carried**|
||**forward**|**Income**|**Expenditure**|**forward**|
||**2019**|||**2019**|
||£|£|£|£|
|**_Unrestricted and designated funds:-_**|||||
|Group Unrestricted**Funds**|594,647|4,311,260|(4,183,200)|722,707|
|**Totalunrestrictedand designatedfunds**|**594,647**|**4,311,260**|**(4,183,200)**|**722,707**|
|**Charity Restricted Funds**|||||
|Sundry RCF Restricted Reserves|147,946|216,322|(177,276)|186,992|
|GLCC|308,274|277,756|(339,032)|?46,998|
|Boehringer Ingleheim Awareness Project|(546)|||(546)|
|**Subidiary**|||||
|**Restricted Funds**|||||
|Cut Films Restricted Reserves|40,208|||40,208|
|**Totalrestricted funds**|**495,882**|**494,078**|**(516,308)**|**473,652**|
|**Total Group Funds**|**1,090,529**|**4,805,338**|**(4,699,508)**|**1,196,359**|



## 

## 

|**Charityonly**|**Funds**|||**Funds**|
|---|---|---|---|---|
||**brought**|||**carried**|
||**forward**|**Income**|**Expenditure**|**forward**|
||**2019**|||**2019**|
|**_Unrestricted and designated funds:-_**|£|£|£|£|
|Unrestricted revenue funds|684,193|2,108,582|(1,971,979)|820,796|
|**Totalunrestrictedand designatedfunds**|**684,193**|**2,108,582**|**(1,971,979)**|**820,796**|
|**_RCFRestricted funds:-_**|||||
|Research-GLCC|308,274|277,756|(339,032)|246,998|
|Research - others|·147,402|2·16,322|("177,276)|186,448|
|**Totalrestricted funds**|455,676|494,078|(516,308)|433,446|
|**Total Charity Funds**|**1,139,869**|**2,602,660**|**(2,488,287)**|**1,254,242**|



## 



## 

## 

|**Change intotal funds over theyear**|||||
|---|---|---|---|---|
||||**Gains &**|**Movement**|
||**Income**|**Expenditure**|**Losses**|**infunds**|
|**Group**|**2020**|**2020**|**2020**|**2020**|
||£|£|£|£|
|**_Unrestricted and designated funds:-_**|||||
|Unrestricted revenue funds|3,249,543|(3,648,630)|17,608|(381,479)|
|**_Restricted funds:-_**|||||
|Restricted Reserves|721,043|(397,668)||323,375|
||**3,970,586**|**(4,046,298)**|**17,608**|**(58,104)**|
|**Change intotal funds over the year**|||||
||||**Gains &**|**Movement**|
||**Income**|**Expenditure**|**Losses**|**infunds**|
|**Charity only**|**2020**|**2020**|**2020**|**2020**|
||£|£|£|£|
|**_Unrestricted and designated funds:-_**|||||
|Unrestricted revenue funds|1,476,067|(1,887,981)|17,608|(394,306)|
|**_Restrictedfunds:- _**|||||
|Restricted Reserves|721,043|(397,668)||323,375|
||**2,197,110**|**(2,285,649)**|**17,608**|**(70,931)**|
||||**Gains &**|**Movement**|
||**Income**|**Expenditure**|**Losses**|**infunds**|
|**Group**|**2019**|**2019**|**2019**|**2019**|
||£|£|£|£|
|**_Unrestricted and designated funds:-_**|||||
|Unrestricted revenue funds|4,311,260|(4,299,307)|116,107|128,060|
|**_Restricted funds:-_**|||||
|Restricted Reserves|494,078|(516,308)||(22,230)|
||**4,805,338**|**(4,815,615)**|**116,107**|**105,830**|
||||**Gains &**|**Movement**|
||**Income**|**Expenditure**|**Losses**|**infunds**|
|**Charity only**|**2019**|**2019**|**2019**|**2019**|
||£|£|£|£|
|**_Unrestricted and designated funds:-_**|||||
|Unrestricted revenue funds|2,108,582|(2,088,086)|116,107|136,603|
|**_Restricted funds:-_**|||||
|Restricted Reserves|494,078|(516,308)||(22,230)|
||**2,602,660**|**(2,604,394)**|**116,107**|**114,373**|





## 

## 

## 

## 

|||||Group|Charity||
|---|---|---|---|---|---|---|
|44|Financial|instruments|2020|2019|2020|2019|
||||£|£|£|£|
||Carrying|amount of financialassets|||||
||Financial|instruments measured at fair value|1,049,672|1,166,509|1,179,267|1,296,109|



##